Akari Therapeutics Plc (AKTX) Climbed 5.22% or 0.1 To Price $1.94 On Monday


Akari Therapeutics Plc (AKTX) climbed 5.22% or 0.1 to $1.94. It is approximately 25357 shares traded, which is 93.08% compare to the average total volume 27241. The market cap of AKTX is $29.54 million. The year to date change is -52.87%. The 52 week price range is from $1.7 to $11.95. Price of AKTX have changed -4.17% during last week. It have changed -13.21% over last month, -3.16% over last 3 months, -22.03% over last 6 months and -54.57% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for AKTX is 1.99. It is 2.58% above current price. The 200-day Moving Averages for AKTX is 2.72. It is 40.21% above current price. The 52-week High is 11.95. It is 515.98% from the current price. The 52-week Low is 1.7. It is -12.37% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of AKTX is 7.07 on 2018-07-31. Short % to float is 1.94%. There are some statistics of AKTX. It is has market cap $29.54 million. The share outstanding is 15.26 million. The average volume is 27241. The percent of top 15 Institution holding is 10.30%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of AKTX is -138.13%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of AKTX is -94.49%.


Tags:

Share this post